The DOI matches its Crossref record.
BIOCHEMISTRY AND PHARMACOLOGY OF COLUBRID SNAKE VENOMS
Abstract
The polyphyletic family Colubridae contains approximately two-thirds of the described species of advanced snakes, and nearly half of these (∼700 species) produce a venom in a specialized cephalic gland, the Duvernoy's gland. Biochemical and pharmacological information is lacking for venoms of most species, and modest detailed information on venom composition is available for only a few species which represent a potential health threat to humans. However, colubrid venoms represent a vast source of novel compounds, and some toxins, such as the 20–26 kD CRISP-related venom proteins (helveprins), have only recently been identified in both colubrid and elapid/viperid venoms. Difficulties associated with extraction have been addressed, and it is now possible to obtain venom sufficient for many analyses from even small species. There appears to be a greater number of venom components shared among the colubrids and the front-fanged snakes than has been previously noted, and it is probable that as analytical methods improve, more similarities will emerge. It is clear that colubrid venoms are homologous with front-fanged snake venoms, but overall composition as well as biological role(s) of colubrid venoms may be quite different. Metallo- and serine proteases have been identified in several colubrid venoms, and phospholipase A2 is a more frequent component than has been previously recognized. Venom phosphodiesterase, acetylcholinesterase and prothrombin activator activities occur in some venoms, and postsynaptic neurotoxins and myotoxins have been partially characterized for venoms from several species. Some venoms show high toxicity toward inbred mice, and others are toxic to birds and/or frogs only. Because many colubrids feed on non-mammalian prey, lethal toxicity toward mice is likely only relevant as a measure of potential risk posed to humans. Development of a non-mammalian vertebrate animal model would greatly facilitate systematic comparisons of the pharmacology of colubrid venoms and their components, and such a model would be more appropriate for evaluation of colubrid venom toxicity. Proteomics has the potential to increase our understanding of these venoms rapidly, but classical approaches to toxinology can also contribute tremendously to this understudied field. As more colubrid venoms are analyzed, new compounds unique to colubrid venoms will be identified, and this work in turn will lead to a better understanding of the evolution and biological significance of snake venoms and venom components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Burmese python genome reveals the molecular basis for extreme adaptation in snakes
Castoe, T. A., de Koning, A. P. J., Hall, K. T., Card, D. C., Schield, D. R., Fujita, M. K., Ruggiero, R. P., Degner, J. F., Daza, J. M., Gu, W., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314475110 · Cited by 287
Self-citationAnticoagulant proteins from snake venoms: structure, function and mechanism
Kini, R. M. (2006) · Biochemical Journal · doi:10.1042/bj20060302 · Cited by 279
Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l -amino acid oxidase
Hiu, J. J., & Yap, M. K. K. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200110 · Cited by 149
Metadata
- Authors
- Mackessy, S. P.
- Venue
- Journal of Toxicology: Toxin Reviews
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 21
- Issue
- 1-2
- Pages
- 43-83
- ISSN
- 0731-3837 (ISSN-L)
- OpenAlex
- W2101703546
- Cited by
- 161
- References
- 0
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BIOCHEMISTRY AND PHARMACOLOGY OF COLUBRID SNAKE VENOMS. https://app.cochat.ai/papers/10.1081/txr-120004741
- The paper
- Mackessy, S. P. (2002). BIOCHEMISTRY AND PHARMACOLOGY OF COLUBRID SNAKE VENOMS. Journal of Toxicology: Toxin Reviews. https://doi.org/10.1081/txr-120004741
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.